Insider Cluster (2 insiders) ·Filed Mar 11, 2026

VRTX

VERTEX PHARMACEUTICALS INC / MA
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago
Insider cluster: 2 insiders, $2.4M total
Actionable Insight • Neutral

These sales are routine from a dollar and volume perspective and not indicative of negative sentiment given their small scale relative to company size. Traders should monitor for additional selling or commentary around earnings or pipeline updates.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
VRTX ▼ -12.93% at T+60d
NEUTRAL call ✗ call lost -12.93% · α vs SPY -24.45% · entry $491.96 → $428.34
Entry anchored
Mar 10, 03:59 PM ET
via exchange tick
T+1d
-2.84%
call -2.84% · α -1.36%
$477.98
settled 7mo ago
T+5d
-8.20%
call -8.20% · α -6.01%
$451.61
settled 7mo ago
T+20d
-9.21%
call -9.21% · α -9.74%
$446.63
settled 6mo ago
T+60d
-12.93%
call -12.93% · α -24.45%
$428.34
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Two Vertex Pharmaceuticals EVPs — the Chief Medical Officer and Chief Commercial Officer — sold shares in open-market transactions totaling approximately $2.45 million. The sales were modest in dollar value relative to the company's $118.4 billion market cap, representing just 0.002% of market value.

Key Financial Metrics

Direction
selling
Total Value
$2.4M
Insiders
2

Key Facts

  • EVP and CMO Carmen Bozic sold 2,329 shares for $1,122,088.91 on March 13, 2026, at $481.79 per share.
  • EVP and Chief Commercial Officer Duncan McKechnie sold 2,633 shares for $1,312,339.86 on March 11, 2026, at $498.42 per share.
  • Total insider sales in cluster: $2,434,428.77 across two C-suite executives.
  • Sales represent approximately 0.002% of Vertex's $118.4B market cap — well below the 0.1% threshold for materiality.

Financial Impact

$2.43 million in total open-market sales by two executives

insider ownershipmarket sentiment

Risk Factors

  • Perception risk if more executives sell in coming days.
  • Potential misinterpretation as bearish signal despite lack of materiality.

Market Snapshot

Exchange
Nasdaq
Analyst Consensus
79% bullish (39 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (2 trades, 7d window)cluster-VRTX-1773777879078
11 reports for VRTX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for VRTX — sortable, filterable
TypeNow
Jul 7, 2026
12w ago
8-K
BULLISH ★ 7/10
$522.25 $522.81▲ +0.11%▼ −1.89%$506.74 (−2.97%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$522.25 $522.81▲ +0.11%▼ −1.89%$506.74 (−2.97%)
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$529.59 $526.73▼ −0.54%▼ −2.26%$506.74 (−4.31%)
Jun 3, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$441.47 $541.69▲ +22.70%▲ +21.08%$506.74 (+14.79%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$430.05 $505.75▲ +17.60%▲ +12.87%$506.74 (+17.83%)
Mar 11, 2026
29w ago
Insider Cluster
NEUTRAL ★ 3/10
$491.96 $428.34▼ −12.93%▼ −24.45%$506.74 (+3.01%)
Feb 25, 2026
31w ago
Insider Cluster
NEUTRAL ★ 4/10
$482.92 $430.44▼ −10.87%▼ −17.82%$506.74 (+4.93%)
Feb 25, 2026
31w ago
Insider Cluster
BEARISH ★ 6/10
$482.92 $430.44▲ +10.87%▲ +17.82%$506.74 (−4.93%)
Feb 25, 2026
31w ago
Insider Cluster
NEUTRAL ★ 3/10
$482.92 $430.44▼ −10.87%▼ −17.82%$506.74 (+4.93%)
Feb 25, 2026
31w ago
Insider Cluster
NEUTRAL ★ 4/10
$482.92 $430.44▼ −10.87%▼ −17.82%$506.74 (+4.93%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 1h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 17, 2026